These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression. Swellam M; El-Aal AA; AbuGabel KM Clin Biochem; 2004 Dec; 37(12):1098-104. PubMed ID: 15589816 [TBL] [Abstract][Full Text] [Related]
24. P16 deletion and mutation analysis in human brain tumors. Barker FG; Chen P; Furman F; Aldape KD; Edwards MS; Israel MA J Neurooncol; 1997 Jan; 31(1-2):17-23. PubMed ID: 9049826 [TBL] [Abstract][Full Text] [Related]
25. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. Tahara H; Smith AP; Gaz RD; Arnold A J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819 [TBL] [Abstract][Full Text] [Related]
26. Variable expression of p16 protein in patients with acute myeloid leukemia without gross rearrangements at the DNA level. Jamal R; Thomas NS; Gale RE; Linch DC Leukemia; 1996 Apr; 10(4):629-36. PubMed ID: 8618439 [TBL] [Abstract][Full Text] [Related]
28. Absence of p16/MTS1 gene mutations in human prostate cancer. Chen W; Weghorst CM; Sabourin CL; Wang Y; Wang D; Bostwick DG; Stoner GD Carcinogenesis; 1996 Dec; 17(12):2603-7. PubMed ID: 9006095 [TBL] [Abstract][Full Text] [Related]
29. [Alteration of p15 and p16 gene in gastric cancer]. Fushida S; Yonemura Y; Kawamura T; Nojima N; Satoh T; Fujita H; Michiwa Y; Fujimura T; Nishimura G; Miwa K; Miyazaki I Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():279-84. PubMed ID: 9263516 [TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of the p16 gene in human neuroblastomas. Castresana JS; Gómez L; García-Miguel P; Queizán A; Pestaña A Mol Carcinog; 1997 Mar; 18(3):129-33. PubMed ID: 9115582 [TBL] [Abstract][Full Text] [Related]
31. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias. Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234 [TBL] [Abstract][Full Text] [Related]
32. Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Ohnishi H; Kawamura M; Ida K; Sheng XM; Hanada R; Nobori T; Yamamori S; Hayashi Y Blood; 1995 Aug; 86(4):1269-75. PubMed ID: 7632931 [TBL] [Abstract][Full Text] [Related]
33. Analysis of p16 gene deletion and point mutation in breast carcinoma. Quesnel B; Fenaux P; Philippe N; Fournier J; Bonneterre J; Preudhomme C; Peyrat JP Br J Cancer; 1995 Aug; 72(2):351-3. PubMed ID: 7640217 [TBL] [Abstract][Full Text] [Related]
34. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Olshan AF; Weissler MC; Pei H; Conway K; Anderson S; Fried DB; Yarbrough WG Oncogene; 1997 Feb; 14(7):811-8. PubMed ID: 9047388 [TBL] [Abstract][Full Text] [Related]
35. p16 gene alterations in nasopharyngeal carcinoma. Lo KW; Huang DP; Lau KM Cancer Res; 1995 May; 55(10):2039-43. PubMed ID: 7743498 [TBL] [Abstract][Full Text] [Related]
36. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621 [TBL] [Abstract][Full Text] [Related]
37. Infrequent somatic mutation of the MTS1 gene in primary bladder carcinomas. Kai M; Arakawa H; Sugimoto Y; Murata Y; Ogawa M; Nakamura Y Jpn J Cancer Res; 1995 Mar; 86(3):249-51. PubMed ID: 7744694 [TBL] [Abstract][Full Text] [Related]
38. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Liew CT; Li HM; Lo KW; Leow CK; Chan JY; Hin LY; Lau WY; Lai PB; Lim BK; Huang J; Leung WT; Wu S; Lee JC Oncogene; 1999 Jan; 18(3):789-95. PubMed ID: 9989830 [TBL] [Abstract][Full Text] [Related]
39. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ. Yin M; Bastacky S; Parwani AV; McHale T; Dhir R Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280 [TBL] [Abstract][Full Text] [Related]
40. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]